Minor histocompatibility antigens HA-8 and PANE1 in the TUNISIAN population.

Rahma Said, Mohamed Hichem Sellami, Houda Kaabi, Slama Hmida
Author Information
  1. Rahma Said: Department of Immunohaematology, National Blood Transfusion Center of Tunis, Tunis, Tunisia. ORCID
  2. Mohamed Hichem Sellami: Department of Immunohaematology, National Blood Transfusion Center of Tunis, Tunis, Tunisia.
  3. Houda Kaabi: Department of Immunohaematology, National Blood Transfusion Center of Tunis, Tunis, Tunisia.
  4. Slama Hmida: Department of Immunohaematology, National Blood Transfusion Center of Tunis, Tunis, Tunisia.

Abstract

BACKGROUND: Minor histocompatibility antigens (mHAgs) are endogenous immunogenic peptides initially identified due to complications detected in several contexts of HLA geno-identical hematopoietic stem cell transplantation (HSCT). In this study, we chose to examine the molecular polymorphism of the mHAgs HA-8 and PANE1 in the Tunisian population.
MATERIAL AND METHODS: This study was conducted on 150 healthy and unrelated individuals. The DNA extraction and Sequence-Specific Primers PCR (PCR-SSP) methods were used for the molecular genotyping of the selected SNPs: PUM3 (rs2173904) and CENPM (rs5758511).
RESULTS: Our results show that, 94% of Tunisians are carriers of the PANE1R allele (immunogenic variant of the PANE1 mHAg) and 68% of Tunisians are carriers of the HA-8R allele (immunogenic variant of the HA-8 mHAg). Furthermore, this study shows that about 5% of the Tunisians are carrier of the PANE1R antigen and its HLA molecule of presentation (the PANE1R/HLA-A*0301 combination). However, only 2% of Tunisians are carrier of the HA-8R/HLA-A*0201 combination, that is, the HA8 immunogenic variant and its specific HLA molecule of presentation.
CONCLUSION: Our results are close to those reported in Caucasian, Asiatic, and African populations, this may be explained by the historical events experienced by Tunisia for millennia. These results could be used for further clinical and anthropological studies.

Keywords

References

  1. Front Pediatr. 2020 Jun 03;8:284 [PMID: 32582592]
  2. Exp Hematol. 2003 Sep;31(9):743-51 [PMID: 12962719]
  3. Tissue Antigens. 2004 Oct;64(4):520-32 [PMID: 15361135]
  4. World J Transplant. 2021 Aug 18;11(8):335-343 [PMID: 34447670]
  5. Ann Hum Biol. 2008 Jul-Aug;35(4):406-15 [PMID: 18608113]
  6. Eur J Med Genet. 2006 Jan-Feb;49(1):43-56 [PMID: 16473309]
  7. Mol Genet Genomic Med. 2022 Nov;10(11):e2050 [PMID: 36036171]
  8. Mitochondrial DNA. 2015 Aug;26(4):593-604 [PMID: 24491098]
  9. Methods Cell Biol. 2022;168:19-39 [PMID: 35366982]
  10. F1000Res. 2017 May 3;6:617 [PMID: 28529723]
  11. PLoS One. 2006 Dec 20;1:e42 [PMID: 17183671]
  12. Transplantation. 2022 Apr 1;106(4):749-753 [PMID: 34699457]
  13. Cancer Sci. 2007 Aug;98(8):1139-46 [PMID: 17521316]
  14. Transplant Proc. 2011 Nov;43(9):3319-23 [PMID: 22099788]
  15. Tissue Antigens. 2010 Jun;75(6):720-3 [PMID: 20136770]
  16. Ann Hum Biol. 2017 Mar;44(2):180-190 [PMID: 27328643]
  17. Tissue Antigens. 1998 Oct;52(4):305-11 [PMID: 9820595]
  18. J Immunol. 2001 Sep 15;167(6):3223-30 [PMID: 11544309]
  19. Biol Blood Marrow Transplant. 2013 Aug;19(8):1244-53 [PMID: 23756210]
  20. Am J Reprod Immunol. 2013 Apr;69(4):304-14 [PMID: 23398025]
  21. J Exp Med. 2001 Jan 15;193(2):195-206 [PMID: 11148223]
  22. Blood. 2017 Feb 9;129(6):791-798 [PMID: 27872059]
  23. Best Pract Res Clin Haematol. 2017 Dec;30(4):333-335 [PMID: 29156205]
  24. Blood. 2003 Jul 15;102(2):621-9 [PMID: 12663445]
  25. Nucleic Acids Res. 1988 Feb 11;16(3):1215 [PMID: 3344216]
  26. J Exp Med. 2022 May 2;219(5): [PMID: 35416936]
  27. Int J Immunogenet. 2013 Dec;40(6):495-501 [PMID: 23480177]
  28. PLoS Genet. 2007 Jun;3(6):e103 [PMID: 17604453]
  29. Ann Hum Biol. 2011 Mar;38(2):156-64 [PMID: 20666704]
  30. Blood. 2006 May 1;107(9):3779-86 [PMID: 16391015]
  31. Trends Immunol. 2008 Dec;29(12):624-32 [PMID: 18952501]
  32. Ann Hum Genet. 1998 Nov;62(Pt 6):531-50 [PMID: 10363131]
  33. Front Immunol. 2017 Mar 20;8:79 [PMID: 28373870]
  34. Hum Immunol. 2005 Nov;66(11):1174-82 [PMID: 16571418]

MeSH Term

Humans
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Minor Histocompatibility Antigens
Alleles
Polymorphism, Single Nucleotide

Chemicals

Minor Histocompatibility Antigens
PUM3 protein, human

Word Cloud

Created with Highcharts 10.0.0immunogenicHA-8PANE1TunisianshistocompatibilityantigensHLAstudyresultsvariantMinormHAgshematopoieticstemcelltransplantationmolecularpopulationusedcarriersPANE1RallelemHAgcarriermoleculepresentationcombinationBACKGROUND:endogenouspeptidesinitiallyidentifiedduecomplicationsdetectedseveralcontextsgeno-identicalHSCTchoseexaminepolymorphismTunisianMATERIALANDMETHODS:conducted150healthyunrelatedindividualsDNAextractionSequence-SpecificPrimersPCRPCR-SSPmethodsgenotypingselectedSNPs:PUM3rs2173904CENPMrs5758511RESULTS:show94%68%HA-8RFurthermoreshows5%antigenPANE1R/HLA-A*0301However2%HA-8R/HLA-A*0201HA8specificCONCLUSION:closereportedCaucasianAsiaticAfricanpopulationsmayexplainedhistoricaleventsexperiencedTunisiamillenniaclinicalanthropologicalstudiesTUNISIANSNPminor

Similar Articles

Cited By